Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent

Human health has been challenged by multi-drug-resistant microorganisms for several decades. Herein, we have developed a main-chain imidazolium oligomer (IBN-1) material to combat broad spectrum of pathogenic strains, including drug-resistant Klebsiella pneumoniae, Vancomycin-resistant enterococcus,...

Full description

Bibliographic Details
Main Authors: Liu, Lihong, Huang, Y., Riduan, S., Gao, S., Yang, Y., Fan, W., Zhang, Y.
Format: Journal Article
Published: 2012
Online Access:http://hdl.handle.net/20.500.11937/24294
_version_ 1848751388425715712
author Liu, Lihong
Huang, Y.
Riduan, S.
Gao, S.
Yang, Y.
Fan, W.
Zhang, Y.
author_facet Liu, Lihong
Huang, Y.
Riduan, S.
Gao, S.
Yang, Y.
Fan, W.
Zhang, Y.
author_sort Liu, Lihong
building Curtin Institutional Repository
collection Online Access
description Human health has been challenged by multi-drug-resistant microorganisms for several decades. Herein, we have developed a main-chain imidazolium oligomer (IBN-1) material to combat broad spectrum of pathogenic strains, including drug-resistant Klebsiella pneumoniae, Vancomycin-resistant enterococcus, Methicillin-resistant Staphylococcus aureus and fluconazole-resistant yeast Cryptococcus neoformans, while displaying minimal hemolysis (HC50/MIC values over 3000) and a very high therapeutic index of 37 for killing S. aureus under inflammatory conditions in vivo.
first_indexed 2025-11-14T07:51:56Z
format Journal Article
id curtin-20.500.11937-24294
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:51:56Z
publishDate 2012
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-242942017-09-13T15:08:24Z Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent Liu, Lihong Huang, Y. Riduan, S. Gao, S. Yang, Y. Fan, W. Zhang, Y. Human health has been challenged by multi-drug-resistant microorganisms for several decades. Herein, we have developed a main-chain imidazolium oligomer (IBN-1) material to combat broad spectrum of pathogenic strains, including drug-resistant Klebsiella pneumoniae, Vancomycin-resistant enterococcus, Methicillin-resistant Staphylococcus aureus and fluconazole-resistant yeast Cryptococcus neoformans, while displaying minimal hemolysis (HC50/MIC values over 3000) and a very high therapeutic index of 37 for killing S. aureus under inflammatory conditions in vivo. 2012 Journal Article http://hdl.handle.net/20.500.11937/24294 10.1016/j.biomaterials.2012.08.006 restricted
spellingShingle Liu, Lihong
Huang, Y.
Riduan, S.
Gao, S.
Yang, Y.
Fan, W.
Zhang, Y.
Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent
title Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent
title_full Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent
title_fullStr Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent
title_full_unstemmed Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent
title_short Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent
title_sort main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent
url http://hdl.handle.net/20.500.11937/24294